TG Therapeutics Inc (NASDAQ:TGTX)

12.20
Delayed Data
As of Feb 16
 -0.45 / -3.56%
Today’s Change
4.50
Today|||52-Week Range
15.35
+48.78%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues152.4K152.4K152.4K152.4K
 
 
 
 
 
Depreciation And Amortization1.1K3.9K15.5K63.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses20.3M55.9M63.3M79.1M
 
 
 
 
 
Research And Development13.7M40.1M47.7M69.2M
 
 
 
 
 
Total Operating Expenses20.3M55.9M63.3M79.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-20.2M-55.7M-63.2M-79.0M
 
 
 
 
 
Extraordinary Credit3.3M720.0K1.0M995.7K
 
 
 
 
 
Extraordinary Charge-2.8M0.000.000.00
 
 
Interest Expense On Debt952.9K930.7K972.7K886.1K
 
 
 
 
 
Other Expenses108.9K95.4K0.00283.5K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-20.5M-55.8M-62.9M-78.3M
 
 
 
 
 
Net Income-20.5M-55.8M-62.9M-78.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS25.4M34.1M45.6M49.0M
 
 
 
 
 
Shares To Calculate EPS Diluted25.4M34.1M45.6M49.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.81-$1.64-$1.38-$1.60
 
 
 
 
 
EPS Diluted-$0.81-$1.64-$1.38-$1.60